A randomised Phase II Trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab (R) in previously treated chronic lymphocytic leukaemia

http://isrctn.org/> ◽

10.1186/isrctn77546448 ◽

2013 ◽

Author(s):

Peter Hillmen

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Phase Ii ◽

Lymphocytic Leukaemia ◽

Phase Ii Trial ◽

Previously Treated

Download Full-text

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

British Journal of Haematology ◽

10.1111/j.1365-2141.2010.08317.x ◽

2011 ◽

Vol 152 (5) ◽

pp. 570-578 ◽

Author(s):

Peter Hillmen ◽

Dena R. Cohen ◽

Kim Cocks ◽

Andrew Pettitt ◽

Hazem A. Sayala ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Phase Ii ◽

Lymphocytic Leukaemia ◽

Phase Ii Trial ◽

Randomized Phase Ii ◽

Previously Treated

Download Full-text

Bendamustine, Followed by Ofatumumab and Ibrutinib in Chronic Lymphocytic Leukaemia (CLL2-BIO): Primary Endpoint Analysis of a Multicentre, Open-Label Phase-II Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3335059 ◽

2019 ◽

Author(s):

Paula Cramer ◽

Julia V. Tresckow ◽

Sandra Robrecht ◽

Jasmin Bahlo ◽

Moritz Fürstenau ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Phase Ii ◽

Primary Endpoint ◽

Lymphocytic Leukaemia ◽

Phase Ii Trial ◽

Open Label Phase

Download Full-text

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

British Journal of Haematology ◽

10.1111/j.1365-2141.2009.07881.x ◽

2009 ◽

Vol 147 (4) ◽

pp. 507-514 ◽

Author(s):

Kristie A. Blum ◽

Anjani Advani ◽

Louis Fernandez ◽

Richard Van Der Jagt ◽

Joseph Brandwein ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Histone Deacetylase ◽

Phase Ii ◽

Histone Deacetylase Inhibitor ◽

Lymphocytic Leukaemia ◽

Phase Ii Study ◽

Deacetylase Inhibitor ◽

Previously Treated

Download Full-text

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia ( CLL ) and thrombocytopenia

British Journal of Haematology ◽

10.1111/bjh.15581 ◽

2018 ◽

Vol 185 (3) ◽

pp. 606-608 ◽

Author(s):

Shilpa Paul ◽

Nitin Jain ◽

Alessandra Ferrajoli ◽

Susan O'Brien ◽

Jan Burger ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Phase Ii ◽

Lymphocytic Leukaemia ◽

Download Full-text

CLL6 (Roche): a randomised, phase II trial of fludarabine, cyclophosphamide and rituximab (FCR) with or without mitoxantrone in previously untreated chronic lymphocytic leukaemia

http://isrctn.org/> ◽

10.1186/isrctn42165735 ◽

2012 ◽

Author(s):

Peter Hillmen

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Phase Ii ◽

Lymphocytic Leukaemia ◽

Download Full-text

Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation

British Journal of Haematology ◽

10.1111/bjh.14342 ◽

2016 ◽

Vol 176 (4) ◽

pp. 573-582 ◽

Author(s):

Abraham M. Varghese ◽

Dena R. Howard ◽

Christopher Pocock ◽

Andy C. Rawstron ◽

George Follows ◽

...

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Minimal Residual Disease ◽

Phase Ii ◽

Lymphocytic Leukaemia ◽

Phase Ii Trial ◽

Residual Disease ◽

Progression Free Survival ◽

Free Survival ◽

Minimal Residual

Download Full-text

A phase II trial of Cyclosporin A in early adverse risk Chronic Lymphocytic Leukaemia (CLL)

http://isrctn.org/> ◽

10.1186/isrctn61297219 ◽

2014 ◽

Author(s):

Rachel Blundred

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Cyclosporin A ◽

Phase Ii ◽

Lymphocytic Leukaemia ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727373020.793562618 ◽

2019 ◽

Author(s):

Corrado Girmenia

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Efficacy And Safety ◽

Phase 3 ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735915890.793561096 ◽

2019 ◽

Author(s):

Mark Bower

Keyword(s):

Phase Ii ◽

Kaposi's Sarcoma ◽

Phase Ii Trial ◽

Kaposi’S Sarcoma ◽

Previously Treated

Download Full-text

A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma

Cancer ◽

10.1002/(sici)1097-0142(19990215)85:4<786::aid-cncr5>3.0.co;2-9 ◽

1999 ◽

Vol 85 (4) ◽

pp. 786-795 ◽

Author(s):

Mace L. Rothenberg ◽

John V. Cox ◽

Russell F. DeVore ◽

John D. Hainsworth ◽

Richard Pazdur ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Multicenter Phase ◽

Previously Treated

Download Full-text